| Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975) |
|---|
| 10/06/2005 | WO2005091754A2 Novel cyclopentenedione antifungal compounds and methods for their use |
| 10/06/2005 | US20050222406 Condensed palatinose in hydrogenated form |
| 10/06/2005 | US20050222055 Heterodimeric conjugates of neomycin-oxazolidinone, their preparation and their use |
| 10/06/2005 | US20050222053 Iridoid-saccharide compound and method of using same |
| 10/06/2005 | US20050220959 Process for producing crystalline maltitol |
| 10/06/2005 | DE102004012676A1 New glucopyranosyl-substituted benzene derivatives are sodium-dependent glucose cotransporter inhibitors, useful for treating e.g. metabolic disorders (type 1 and type 2 diabetes mellitus or metabolic acidosis) |
| 10/06/2005 | CA2560931A1 Novel cyclopentenedione antifungal compounds and methods for their use |
| 10/06/2005 | CA2557801A1 Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof |
| 10/05/2005 | EP1581165A2 Novel factor viia inhibiting compounds |
| 10/05/2005 | EP0929234B2 Tablets containing a sweetening mixture |
| 10/05/2005 | CN1678340A O-derivatized nocathiacin derivatives |
| 10/04/2005 | US6951934 Method for preparing functionalized β-(1,3)-glucan derivatives |
| 09/29/2005 | WO2005090382A1 Antithrombotic compound |
| 09/29/2005 | WO2005090368A1 Synthetic membrane anchors |
| 09/29/2005 | WO2005089522A2 Spermicidal and virucidal properties of various forms of sophorolipids |
| 09/29/2005 | WO2005072765A3 An efficient method to synthesize benzyl group-protected alpha-pentagalloylglucose (α-pgg) and its analogues |
| 09/29/2005 | US20050215648 Oxymethylidene-substituted, e.g., 2-(1-methoxy-ethylidene)-cyclopent-4-ene-1,3-diones; inhibit fluconazole-resistant C. albicans strains; may be used for the treatment of life-threatening candidiasis associated with immunocompromised patients. |
| 09/29/2005 | US20050215492 Ameliorant for chemical treament of cancer |
| 09/29/2005 | US20050215491 Adjustment of growth factor; to treat a condition ameliorated by administration of an Inositol Phosphoglycans second messenger or an Inositol Phosphoglycans antagonist thereof; compounds are based on the 1,6 linkage of a sugar residue and a cyclitol |
| 09/29/2005 | US20050215454 providing a starting mixture comprising an alk(en)yl polyglycoside, and one or more fatty alcohols, reacting starting mixture with a compound selected from omega -halocarboxylic acids, omega -halocarboxylic acid salts, omega -halocarboxylic acid esters or mixture to perform esterification |
| 09/29/2005 | CA2555036A1 Antithrombotic compound |
| 09/28/2005 | EP1578757A2 Fluorogenic enzyme substrates and methods of preparation |
| 09/28/2005 | EP1578723A2 Process for the preparation of oxazolidinones and method of use thereof |
| 09/28/2005 | EP0944639A4 Synthetic glycoamines, methods for their use that affect cell |
| 09/28/2005 | CN1675233A Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides |
| 09/28/2005 | CN1675232A Derivatives of monosaccharides for drug discovery |
| 09/28/2005 | CN1675231A Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors and intermediates therefor |
| 09/28/2005 | CN1674896A Pharmaceutical compositions comprising FK506 derivatives and the ir use for the treatment of allergic diseases |
| 09/27/2005 | US6949663 Multilayer; anticoagulant |
| 09/27/2005 | CA2121997C 3-deoxy oligosaccharides, processes for preparing them and pharmaceutical compositions containing them |
| 09/22/2005 | WO2005087843A1 Grafted polymer comprising a polyorganosiloxane backbone and gylcoside units |
| 09/22/2005 | WO2005087785A2 Method for the alkoxylation of alkyl and/or alkenyl polyglycosides |
| 09/22/2005 | US20050209309 Aryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same |
| 09/22/2005 | US20050209174 Especially conjugating derivatives of paclitaxel, cholesterol, camptothecin, and rhodamine123 to transferrins, side effect reduction |
| 09/22/2005 | US20050209166 Metabolic disorders like diabetes; inhibits sodium-dependent glucose cotransporter; 1-chloro-2-(4-cyclopentyloxybenzyl)-4-( beta -D-glucopyranos-1-yl)-benzene |
| 09/22/2005 | CA2557363A1 Method for the alkoxylation of alkyl and/or alkenyl polyglycosides |
| 09/21/2005 | EP1577316A1 Sugar-chain asparagine derivatives and processes for the preparation thereof |
| 09/21/2005 | EP0690868B2 Alkyl glucoside and use thereof |
| 09/21/2005 | CN1671724A Prodrug, medicinal utilization thereof and process for producing the same |
| 09/21/2005 | CN1671723A Novel difluorinated gem compounds, preparation methods thereof and applications of same |
| 09/15/2005 | WO2005085264A1 Sulfated oligosaccharide derivatives |
| 09/15/2005 | US20050203061 Produrg which can reduce side effects of drug by utilizing an enzyme whose enzymatic activity has difference between target site of drug and site to express side effects; a glycosidase, for example, beta -glucuronidase, may be used as enzyme; salbutamol is an example of the drug |
| 09/15/2005 | US20050201939 Dye-peptide complex; supplying to tumor cells; for diagnostic imaging and therapy; biocompatibility |
| 09/15/2005 | DE4126475B4 13-Dihydro-3'-(2-Alkoxy-4-morpholinyl)anthracycline, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Zusammensetzungen 13-dihydro-3 '- (2-alkoxy-4-morpholinyl) anthracyclines, processes for their preparation, their use and compositions containing them |
| 09/15/2005 | CA2557989A1 Sulfated oligosaccharide derivatives |
| 09/14/2005 | EP1574516A1 Antithrombotic compound |
| 09/14/2005 | EP1574515A2 Production method of 2-deoxy-L-ribose compound |
| 09/14/2005 | EP1572708A1 Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof |
| 09/14/2005 | EP1572707A1 Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof |
| 09/14/2005 | EP1572706A1 Method for producing alkyl oligoglucoside- and/or alkenyl oligoglucoside carboxylic acid salts |
| 09/14/2005 | EP1572114A2 Glycosylceramide analogues |
| 09/14/2005 | EP1296700B1 Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root |
| 09/14/2005 | EP0981343B1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 09/14/2005 | CN1668755A Galactosyl isomalt, method for production and use thereof |
| 09/14/2005 | CN1668741A Production of polyketides and other natural products |
| 09/14/2005 | CN1668627A Process for producing glycoside |
| 09/14/2005 | CN1668561A Remedy |
| 09/08/2005 | US20050197290 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 09/08/2005 | DE102004017793A1 Use of trioxacarcins for treatment and prevention of infectious diseases, also new trioxacarcins for treatment of e.g. tumors, inflammatory and autoimmune diseases |
| 09/07/2005 | EP1570849A1 Freeze-dried preparation of stabilized anthracycline compound |
| 09/06/2005 | US6939859 Skin preparations for external use |
| 09/06/2005 | US6939857 Compounds and their uses |
| 09/06/2005 | US6939532 Versatile hydrophilic dyes |
| 09/01/2005 | WO2005080549A2 Trioxacarcins and their use against infections |
| 09/01/2005 | US20050192432 From mutated Streptomyces argillaceous; antitumor agents; hypercalcemia; hypercalcuria |
| 09/01/2005 | US20050192236 A substantially crystalline clindamycin free base of three polymorphic/pseudopolymorphic forms; water insoluble so useful for sustained release formulations; storage stability; powder x-ray diffraction; differential scanning calorimetry; bactericides |
| 09/01/2005 | US20050191367 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 09/01/2005 | US20050188861 Strapping of bank notes |
| 09/01/2005 | DE102004008302A1 Preparation of alkoxylated alkyl and/or alkenyl polyglycosides, useful as adjuvants in agro-chemical formulations e.g. in herbicides, comprises reaction of alkylene oxides with alkyl- and alkenyl polyglycosides |
| 08/31/2005 | CN1662547A Process for producing crystalline maltitol |
| 08/31/2005 | CN1660870A Method for synthesizing ramification of diclofenac of glucosamine |
| 08/31/2005 | CN1660869A Method for synthesizing ramification of diclofenac of glucosamine |
| 08/30/2005 | US6936701 Glycoconjugates and methods |
| 08/30/2005 | CA1341489C Family of primate hematopoietic growth factors |
| 08/25/2005 | WO2005077965A1 Sugar chain ligand composite and method of analyzing protein with the ligand composite |
| 08/25/2005 | WO2005077964A1 Derivatives of saccharides and itols having an o-n- alcanoyl group and an o-ortho-acetylsalicyloyl group, uses thereof as food additives or non-food additives or as medicaments |
| 08/25/2005 | WO2005077963A1 Saccharide and itol derivatives having an o-alkyl group or an o-alkyl group and an o-n butanyl group, uses as medicines in tumoral or benign proliferative pathologies |
| 08/25/2005 | WO2005062824A3 Anti-hypercholesterolemic compounds |
| 08/25/2005 | US20050187384 Process for the preparation of 2'-halo-beta-L-arabinofuranosyl nucleosides |
| 08/25/2005 | US20050187171 Glycomimetic antagonists for both E-and P-selectins |
| 08/25/2005 | US20050187167 Polyene polyketides, processes for their production and their use as a pharmaceutical |
| 08/25/2005 | CA2556406A1 Sugar chain ligand composite and method of analyzing protein with the ligand composite |
| 08/24/2005 | CN1659177A Gangliosides with a modified acyl function |
| 08/24/2005 | CN1658757A Antihelminthic anthraquinones and method of use thereof |
| 08/24/2005 | CN1657533A Method for oxtracting beta-glucoside from waste mushroom culture medium |
| 08/24/2005 | CN1216063C Synthesis of oxo synthol alkyl glucoside from oxo synthol and glucose by one step process |
| 08/24/2005 | CN1216018C Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |
| 08/23/2005 | US6933352 Amphiphilic compounds having a dendritic branch structure |
| 08/23/2005 | US6933116 Nucleic acid ligand binding site identification |
| 08/18/2005 | WO2005075493A1 Glycolipid-containing compound, biosensor having the same fixed thereto, fine particle containing glycolipid, detection reagent containing the fine particle, and method of detecting compound combining with sugar |
| 08/18/2005 | WO2005075492A1 Prodrug comprising 5-aminosalicylate glycoside |
| 08/18/2005 | WO2005075491A1 6r-(3,6-dideoxy-l-arabino-hexopyranosyloxy)heptanoic acid, preparation process for the same and dauer effect thereof |
| 08/18/2005 | WO2005075453A1 Linker compound, ligand complex and process for producing them |
| 08/18/2005 | WO2005054264A8 Glycomimetic antagonists for both e- and p-selectins |
| 08/18/2005 | WO2005007665A3 Lincomycin derivatives possessing antibacterial activity |
| 08/18/2005 | US20050182000 Anti-inflammatory compounds derived from Pseudopterogorgia elisabethae |
| 08/18/2005 | US20050180945 glycopolymers, useful for biomolecular recognition processes which can be immobilized onto surfaces; easily synthesized; sulfated glycopolymers which are useful for reducing blood coagulation; for providing surfaces capable of binding to bioactive molecules for use in bio and immunochemical assays |
| 08/18/2005 | CA2554091A1 Prodrug comprising 5-aminosalicylate glycoside |
| 08/18/2005 | CA2519329A1 6r-(3,6-dideoxy-l-arabino-hexopyranosyloxy)heptanoic acid, preparation process for the same and dauer effect thereof |
| 08/17/2005 | EP1563840A1 Dengue virus infection inhibitor |